Lei Xue
- Molecular Biology top 10%
- Cancer Research top 5%
- Cell Biology top 5%
- Oncology top 10%
- Immunology
- Topics
- Cancer-related molecular mechanisms research (8 papers)Hippo pathway signaling and YAP/TAZ (8 papers)RNA modifications and cancer (7 papers)
- Cited by
- Cancer ResearchAgingCell Biology
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Lei Xue
73 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 1.0k
- Cancer Research 337
- Cell Biology 301
- Oncology 247
- Immunology 189
Countries citing papers authored by Lei Xue
This map shows the geographic impact of Lei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Xue more than expected).
Fields of papers citing papers by Lei Xue
This network shows the impact of papers produced by Lei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Xue. The network helps show where Lei Xue may publish in the future.
Co-authorship network of co-authors of Lei Xue
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Xue. A scholar is included among the top collaborators of Lei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Xue. Lei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 22 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 16 | |
| 7 | 1 | |
| 8 | 20 | |
| 9 | 13 | |
| 10 | 38 | |
| 11 | 19 | |
| 12 | 38 | |
| 13 | 52 | |
| 14 | 39 | |
| 15 | 15 | |
| 16 | 54 | |
| 17 | 3 | |
| 18 | 1 | |
| 19 | 6 | |
| 20 | 52 |
About Lei Xue
Lei Xue is a scholar working on Cancer Research, Cell Biology and Molecular Biology, having authored 74 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Hippo pathway signaling and YAP/TAZ (8 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (337 citations), Aging (34 citations) and Cell Biology (301 citations). Lei Xue has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Markus Noll, Xianjue Ma, Yi-Hui Lin, Jun Li, Degang Liu, Weijie Zhang, Jianhua Xu, Qingxia Fan, Wenzhe Li and Ernestina Melicoff. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Environmental Science & Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.